hypothyroidism
HYPOTHYROIDISM
Hypothyroidism is a common endocrine disorder where in the thyroid does not make enough thyroid hormone.
Subclinical/mild hypothyroidism refers to the state of slightly increased serum TSH with normal serum FT4 in patients who are usually asymptomatic.
Most common cause of primary hypothyroidism is autoimmune thyroiditis or Hashimoto's disease.
Levothyroxine is the first-line agent for treatment of hypothyroidism.

Pharmacotherapy

Levothyroxine

  • 1st-line agent for treatment of hypothyroidism
  • May be used to manage myxedema coma
  • Safe for use in pregnancy
  • Actions:
    • Used as a replacement therapy in hypothyroidism to suppress TSH secretion
    • Long half-life (T½), slow onset, regular bioconversion which is appropriately regulated by the tissues to the biologically active compound T3
  • Effects: Safe and predictable effects
    • Requires several weeks to achieve peak therapeutic effects with regular oral dosing
  • Due to different bioavailability of the various preparations of Levothyroxine, patients are encouraged to use the same brand of Levothyroxine
    • If a change in brand is needed, the patient’s serum TSH should be retested and dosage of Levothyroxine be re-titrated

Liothyronine

  • Actions:
    • Short T½, rapid onset
    • Biologically active compound (no conversion is necessary)
    • Used as a replacement therapy in hypothyroidism to suppress TSH secretion
  • Generally not recommended for routine treatment of hypothyroidism due to its rapid onset and turnover which requires more frequent administration and increases the risk of hyperthyroidism
  • Useful in management of myxedema coma (when its rapid onset and short duration of action are required)
  • Effects: Require 3 days to achieve peak therapeutic effects
Note: Desiccated thyroid hormones (with variable proportion of T3 and T4), combinations of thyroid hormones and T3 alone are generally not recommended for treatment of hypothyroidism.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
02 May 2019
At a recent Abbott lunch symposium held in conjunction with the joint 12th International Diabetes FederationWestern Pacific Region Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in KualaLumpur, Professor Shashank R. Joshi extensively discussed the issue of diabetes in obesity and the role of nutritionalintervention in addressing this growing problem.
Dr Joslyn Ngu, 19 Jun 2018

The transcultural Diabetes Nutrition Algorithm (tDNA) which involves a structured low-calorie meal plan, diabetes-specific meal replacements and enhanced physical activity, is effective for weight loss in patients with type 2 diabetes, a local study shows. [BMJ Open Diabetes Res Care 2017;5(1):e000384. Doi:10.1136/bmjdrc-2016-000384th]